HMGB3 promotes the malignant phenotypes and stemness of epithelial ovarian cancer through the MAPK/ERK signaling pathway by Hanlin Ma, Gonghua Qi, Fang Han, Panpan Gai, Jiali Peng, Beihua Kong

Get full text

HMGB3 promotes PARP inhibitor resistance through interacting with PARP1 in ovarian cancer by Hanlin Ma, Gonghua Qi, Fang Han, Wei Lu, Jiali Peng, Rongrong Li, Shi Yan, Cunzhong Yuan, Beihua Kong

Get full text

Clinical features and prognostic factors analysis of intravenous leiomyomatosis by Jingying Chen, Jingying Chen, Hualei Bu, Zhaoyang Zhang, Zhaoyang Zhang, Ran Chu, Ran Chu, Gonghua Qi, Gonghua Qi, Chen Zhao, Chen Zhao, Qiuman Wang, Qiuman Wang, Xinyue Ma, Xinyue Ma, Huan Wu, Huan Wu, Zhiyuan Dou, Zhiyuan Dou, Xia Wang, Beihua Kong, Beihua Kong

Get full text

Targeting TCF19 sensitizes MSI endometrial cancer to anti-PD-1 therapy by alleviating CD8+ T cell exhaustion via TRIM14-IFN-β axis by Xinyue Ma, Qiuman Wang, Chenggong Sun, Indu Agarwal, Huan Wu, Jingying Chen, Chen Zhao, Gonghua Qi, Qiuli Teng, Cunzhong Yuan, Shi Yan, Jiali Peng, Rongrong Li, Kun Song, Qing Zhang, Beihua Kong

Get full text